Pharmaceuticals - Community Register


Community list of not active veterinary medicinal products


Product information

Invented name: Advasure
Auth. number : EU/2/00/025
Active substance : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI09 - Immunologicals for suidae
Pharmacological subgroup: QI09A - Pig
Chemical subgroup: QI09AA - Inactivated viral vaccines
Chemical substance: QI09AA06 - classical swine fever virus
(See WHO ATCvet Index)
Indication: Active immunisation of pigs, over the age of 2 weeks, against Classical Swine Fever (CSF), to prevent mortality, reduce clinical signs of the disease and the excretion of field virus
Marketing Authorisation Holder: Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/02/2001 Centralised - Authorisation EMEA/V/C/53 (2001)208 of 02/02/2001
06/07/2001 Centralised - Variation (no change in Commission Decision) EMEA/V/C/53/I/1
11/04/2003 Centralised - Variation EMEA/V/C/53/II/2 (2003)1249 of 09/04/2003
20/04/2005 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/53/T/3 (2005)1275 of 18/04/2005
20/09/2005 Centralised - Variation EMEA/V/C/53/IB/4
Updated with Decision(2006)498 of 13/02/2006
15/02/2006 Centralised - Renewal EMEA/V/C/53/R/5 (2006)498 of 13/02/2006
08/02/2008 Centralised - Withdrawal (2008)533 of 06/02/2008